Post written by Ala Sharara, MD, AGAF, FACG, FRCP, from the Division of Gastroenterology and Hepatology, American University of Beirut Medical Center, Beirut, Lebanon.

The target sedation level for endoscopic procedures is conscious sedation. However, patients might progress to deeper levels of sedation, such as deep sedation and general anesthesia. To our knowledge, no study has specifically investigated the degree of sedation achieved in clinical practice and the time spent at each level using a standardized conscious sedation regimen during these procedures.
Therefore, we conducted a prospective study to assess degree of sedation in patients undergoing propofol-based endoscopy. We used the bispectral index (BIS), a noninvasive tool that uses electroencephalographic monitoring to provide anesthesiologists with a numerical representation of the depth of sedation and the effects of anesthesia on patients.
The monitoring parameters required by the American Society of Anesthesiologists and the American Society for Gastrointestinal Endoscopy—heart rate, blood pressure, continuous electrocardiography, pulse oximetry, capnography, and patient reactivity—may not be accurate enough in assessing depth of sedation during GI endoscopy, even for experienced anesthesiologists. For some patients, any oversedation may result in delayed recovery, cognitive dysfunction, and other related adverse events.
Our finding that the line between conscious sedation and general anesthesia, as well as a deep hypnotic state, was frequently crossed is striking. Notably, 88% of patients spent more than one-third of the total sedation time in general anesthesia and more than 10% in a deep hypnotic state. Younger age was the only predictor for a BIS score below 60, and no significant predictors were identified for a BIS score below 40 in the multivariate analysis. Patients who experienced a BIS score below 40 had a higher incidence of postprocedural dizziness.
The number needed to harm was 6, indicating that one could expect prolonged dizziness in 1 of every 6 patients who experienced a deep hypnotic state during their procedural sedation. Thus, endoscopists and anesthesiologists should develop new objective and reliable depth-monitoring devices to limit oversedation and related adverse events.
To our knowledge, this study is the first to investigate time spent by patients undergoing propofol-based GI endoscopy in different stages of sedation using BIS monitoring.

Illustrative recording of dips in the bispectral index (BIS) recorded during endoscopy: A, BIS score <60; B, BIS score <40. The y axis denotes the BIS score and the x axis indicates time (in minutes).
Visit iGIE’s Facebook, X/Twitter, and YouTube accounts for more content from the ASGE peer-reviewed journal that launched in December 2022.
Read the full article online.
The information presented in Endoscopedia reflects the opinions of the authors and does not represent the position of the American Society for Gastrointestinal Endoscopy (ASGE). ASGE expressly disclaims any warranties or guarantees, expressed or implied, and is not liable for damages of any kind in connection with the material, information, or procedures set forth.
Dear Dr. Sharara,
Congratulations on your excellent paper.
In 2013, our group conducted a RCT comparing two sedation regimens for upper GI endoscopy. BIS was employed to evaluate the level of sedation. We would like to share our findings for your future reference.
Kindest regards,
Fauze Maluf-Filho
Department of Gastroenterology – University of São Paulo
fauze.maluf@hc.fm.usp.br
fauze.maluf@terra.com.br
World Journal of Gastroenterology 2013 Jun 14;19(22):3439-46.
doi: 10.3748/wjg.v19.i22.3439.
Deep sedation during gastrointestinal endoscopy: propofol-fentanyl and midazolam-fentanyl regimens
Abstract
Aim: To compare deep sedation with propofol-fentanyl and midazolam-fentanyl regimens during upper gastrointestinal endoscopy.
Methods: After obtaining approval of the research ethics committee and informed consent, 200 patients were evaluated and referred for upper gastrointestinal endoscopy. Patients were randomized to receive propofol-fentanyl or midazolam-fentanyl (n = 100/group). We assessed the level of sedation using the observer’s assessment of alertness/sedation (OAA/S) score and bispectral index (BIS). We evaluated patient and physician satisfaction, as well as the recovery time and complication rates. The statistical analysis was performed using SPSS statistical software and included the Mann-Whitney test, χ² test, measurement of analysis of variance, and the κ statistic.
Results: The times to induction of sedation, recovery, and discharge were shorter in the propofol-fentanyl group than the midazolam-fentanyl group. According to the OAA/S score, deep sedation events occurred in 25% of the propofol-fentanyl group and 11% of the midazolam-fentanyl group (P = 0.014). Additionally, deep sedation events occurred in 19% of the propofol-fentanyl group and 7% of the midazolam-fentanyl group according to the BIS scale (P = 0.039). There was good concordance between the OAA/S score and BIS for both groups (κ = 0.71 and κ = 0.63, respectively). Oxygen supplementation was required in 42% of the propofol-fentanyl group and 26% of the midazolam-fentanyl group (P = 0.025). The mean time to recovery was 28.82 and 44.13 min in the propofol-fentanyl and midazolam-fentanyl groups, respectively (P < 0.001). There were no severe complications in either group. Although patients were equally satisfied with both drug combinations, physicians were more satisfied with the propofol-fentanyl combination.
Conclusion: Deep sedation occurred with propofol-fentanyl and midazolam-fentanyl, but was more frequent in the former. Recovery was faster in the propofol-fentanyl group.
Keywords: Adverse effects; Anesthetic administration; Anesthetic dose; Deep sedation; Endoscopy.